Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 40Colorectal Neoplasms 24Carcinoma, Non-Small-Cell Lung 18Rectal Neoplasms 14Lung Neoplasms 13Stomach Neoplasms 12Esophageal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 9Esophageal Squamous Cell Carcinoma 9Prostatic Neoplasms 8Pancreatic Neoplasms 8Neoplasm Metastasis 8Colonic Neoplasms 8Carcinoma, Hepatocellular 8Adenocarcinoma Of Esophagus 8Sarcoma 7Ovarian Neoplasms 7Neoplasms 6Head and Neck Neoplasms 6Urinary Bladder Neoplasms 5Osteosarcoma 5Liver Neoplasms 5Kidney Neoplasms 4Inflammatory Breast Neoplasms 4Fallopian Tube Neoplasms 4Carcinoma, Renal Cell 4Breast Neoplasms, Male 4Turcot syndrome 3Multiple Myeloma 3Locally Advanced Rectal Cancer 3

Interventions

Rituximab 57Cyclophosphamide 42fludarabine phosphate 29Peripheral Blood Stem Cell Transplantation 29Mycophenolic Acid 22Dexamethasone 21Tacrolimus 20Whole-Body Irradiation 18Bortezomib 18Cyclosporine 15Busulfan 13ibrutinib 12Methotrexate 12Melphalan 12Radiotherapy 11Etoposide 11Antilymphocyte Serum 10zanubrutinib 9Calcium Dobesilate 9venetoclax 7Sirolimus 7idelalisib 6Prednisone 6Lenalidomide 6Filgrastim 6Doxorubicin 6Cyclosporins 6Bendamustine Hydrochloride 6Alemtuzumab 6sargramostim 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Waldenstrom Macroglobulinemia × Neoadjuvant Therapy × Clear all
NCT07259122 2025-12-02

ZBR in WM

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Not yet recruiting
43 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡